PD Supplier Update - Are your patients suffering from dandruff? | Pharmacy Daily

PD Supplier Update – Are your patients suffering from dandruff?

November 27, 2024

Nizoral has partnered with Pharmacy Daily to highlight its range of effective anti-dandruff treatments.

Are your patients suffering from dandruff?

Nizoral 1% – Lower strength Anti-Dandruff Treatment

Deep conditioning.
Suitable for people suffering from mild dandruff.
Indicated for the treatment of dandruff associated with fungal infections.
Provides effective deep conditioning.

Nizoral 2% – Higher strength Anti-Dandruff Treatment

Clinically tested to be effective in close to 9 out of 10 users*.
Indicated for treatment of medically diagnosed severe dandruff and seborrheic dermatitis of the scalp.

For more information click HERE.

*Petr RU, Richarz-Barhauer U. Br. J. Dermatol. 1995:132(3):441-5

Click here to download the PD Supplier Update – Are your patients suffering from dandruff?

Other recent headlines

PD breaking news – Blackmores Institute Director Dr Lesley Braun departs
Wednesday | Dec 18 2024

After more than 10 years leading the Blackmores Institute, Dr Lesley Braun is leaving the company….
Consumers’ support strong
Wednesday | Dec 18 2024

THE Pharmaceutical Society of Australia (PSA) has released the Pharmacists in 2030: Strengthening consumer voices report, an addendum to the Pharmacists in 2030 vision released in August this year (PD 07 Aug).
ADHD drugs work short-term
Wednesday | Dec 18 2024

THE most comprehensive analysis of evidence to date on ADHD treatment in adults has found that while some medications are effective in the short-term, other interventions are ineffective or poorly tolerated, and there is little data on long-term treatment.

to top